A multicenter randomized controlled trial of two group education programs for fatigue in multiple sclerosis: Long-term (12-month) follow-up at one site

Abstract

Background:

A four-site RCT of Fatigue: Take Control (FTC), a multicomponent group program, found no significant differences from a control program, MS: Take Control (MSTC), in fatigue on the Modified Fatigue Impact Scale (MFIS) through 6 months.

Objective:

Assess FTC for a delayed effect on fatigue.

Methods:

Of 78 subjects at one site, 74 randomized to FTC or MSTC completed the MFIS at 12 months.

Results:

Compared to baseline, FTC produced greater improvements in MFIS scores than MSTC (FTC −8.9 (confidence interval (CI): 32.2, 45), MSTC −2.5 (CI 39.6, 47.7), p = 0.03) at 12 months.

Conclusion:

The delayed effect of FTC on fatigue suggests the need for longer follow-up when assessing interventions for fatigue.

Keywords

Multiple sclerosis fatigue rehabilitation self-care clinical trial symptom management

Get full access to this article

View all access options for this article.

References

Freal

Kraft

Coryell

JK.

Symptomatic fatigue in multiple sclerosis. Arch Phys Med Rehabil 1984; 65: 135–138.

Multiple Sclerosis Council for Clinical Practice Guidelines. Fatigue and multiple sclerosis: Evidence-based management strategies for fatigue in multiple sclerosis. Washington, DC: Paralyzed Veterans of America, 1998.

Thomas

Kersten

et al . One year follow-up of a pragmatic multi-centre randomised controlled trial of a group-based fatigue management programme (FACETS) for people with multiple sclerosis. BMC Neurol 2014; 14: 109.

Hugos

Chen

et al . A multicenter randomized controlled trial of two group education programs for fatigue in multiple sclerosis: Short- and medium-term benefits. Mult Scler 2019; 25: 275–285.

Noseworthy

Vandervoort

Wong

et al . Interrater variability with the Expanded Disability Status Scale (EDSS) and Functional Systems (FS) in a multiple sclerosis clinical trial. Neurology 1990; 40: 971–975.

Fisk

Pontefract

Ritvo

et al . The impact of fatigue on patients with multiple sclerosis. Can J Neurol Sci 1994; 21: 9–14.

Flachenecker

Kumpfel

Kallmann

et al . Fatigue in multiple sclerosis: A comparison of different rating scales and correlation to clinical parameters. Mult Scler 2002; 8: 523–526.

Putzki

Yaldizli

Tettenborn

et al . Multiple sclerosis associated fatigue during natalizumab treatment. J Neurol Sci 2009; 285: 109–113.

Wingerchuk

Benarroch

O’Brien

et al . A randomized controlled crossover trial of aspirin for fatigue in multiple sclerosis. Neurology 2005; 64: 1267–1269.

10.

Kos

Duportail

D’hooghe

et al . Multidisciplinary fatigue management programme in multiple sclerosis: A randomized clinical trial. Mult Scler 2007; 13: 996–1003.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.11 MB

0.04 MB